{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:30:34Z","timestamp":1789475434304,"version":"build-2803163510"},"reference-count":225,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Neutrophils are important components of the innate immune system that mediate pathogen defense by multiple processes including phagocytosis, release of proteolytic enzymes, production of reactive oxygen species, and neutrophil extracellular trap formation. Abnormalities of neutrophil count and function have been described in the setting of HIV infection, with the majority of antiretroviral agents (ARVs), excluding zidovudine, having been reported to correct neutropenia. Questions still remain, however, about their impact on neutrophil function, particularly the possibility of persistent neutrophil activation, which could predispose people living with HIV to chronic inflammatory disorders, even in the presence of virally-suppressive treatment. In this context, the effects of protease inhibitors and integrase strand transfer inhibitors, in particular, on neutrophil function remain poorly understood and deserve further study. Besides mediating hemostatic functions, platelets are increasingly recognized as critical role players in the immune response against infection. In the setting of HIV, these cells have been found to harbor the virus, even in the presence of antiretroviral therapy (ART) potentially promoting viral dissemination. While HIV-infected individuals often present with thrombocytopenia, they have also been reported to have increased platelet activation, as measured by an upregulation of expression of CD62P (P-selectin), CD40 ligand, glycoprotein IV, and RANTES. Despite ART-mediated viral suppression, HIV-infected individuals reportedly have sustained platelet activation and dysfunction. This, in turn, contributes to persistent immune activation and an inflammatory vascular environment, seemingly involving neutrophil-platelet-endothelium interactions that increase the risk for development of comorbidities such as cardiovascular disease (CVD) that has become the leading cause of morbidity and mortality in HIV-infected individuals on treatment, clearly underscoring the importance of unraveling the possible etiologic roles of ARVs. In this context, abacavir and ritonavir-boosted lopinavir and darunavir have all been linked to an increased risk of CVD. This narrative review is therefore focused primarily on the role of neutrophils and platelets in HIV transmission and disease, as well as on the effect of HIV and the most common ARVs on the numbers and functions of these cells, including neutrophil-platelet-endothelial interactions.<\/jats:p>","DOI":"10.3389\/fimmu.2021.634386","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T04:20:06Z","timestamp":1615522806000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets"],"prefix":"10.3389","volume":"12","author":[{"given":"Morris","family":"Madzime","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Rossouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette J.","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jpids\/pit074","article-title":"Executive summary: guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics","volume":"2","author":"Siberry","year":"2013","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/infdis\/jiv236","article-title":"Opportunistic infections and mortality: still room for improvement","volume":"212","author":"Masur","year":"2015","journal-title":"J Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1874613601408010066","article-title":"Immune suppression by myeloid cells in HIV infection: new targets for immunotherapy","volume":"8","author":"Mehraj","year":"2014","journal-title":"Open AIDS J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.4VMR1114-555R","article-title":"Neutrophils in viral infections: current concepts and caveats","volume":"98","author":"Galani","year":"2015","journal-title":"J Leukoc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00441-017-2763-0","article-title":"Neutrophils in viral infection","volume":"371","author":"Naumenko","year":"2018","journal-title":"Cell Tissue Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/516120","article-title":"The role of platelets in antimicrobial host defense","volume":"25","author":"Yeaman","year":"1997","journal-title":"Clin Infect Dis."},{"key":"B7","first-page":"65","article-title":"Platelets: essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr Trends Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2015.00082","article-title":"Platelets and infections - complex interactions with bacteria","volume":"6","author":"Hamzeh-Cognasse","year":"2015","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1753425918789255","article-title":"Start a fire, kill the bug: the role of platelets in inflammation and infection","volume":"24","author":"Deppermann","year":"2018","journal-title":"Innate Immun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The Era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/ijms20071730","article-title":"Understanding platelets in infectious and allergic lung diseases","volume":"20","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.4049\/jimmunol.178.10.6017","article-title":"Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation","volume":"178","author":"Danese","year":"2007","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11904-018-0370-7","article-title":"The dual role of neutrophils in HIV infection","volume":"15","author":"Hensley-McBain","year":"2018","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000487756","article-title":"Neutrophils and bacterial immune evasion","volume":"10","author":"Kobayashi","year":"2018","journal-title":"J Innate Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"39860","DOI":"10.1074\/jbc.M605898200","article-title":"Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing","volume":"281","author":"Winterbourn","year":"2006","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1600-065X.2007.00550.x","article-title":"How human neutrophils kill and degrade microbes: an integrated view","volume":"219","author":"Nauseef","year":"2007","journal-title":"Immunol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1245049","DOI":"10.1155\/2016\/1245049","article-title":"Role of ROS and RNS sources in physiological and pathological conditions","volume":"2016","author":"Di Meo","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"748550","DOI":"10.1128\/JVI.74.18.8550-8557.2000","article-title":"CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells","volume":"74","author":"Olinger","year":"2000","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1128\/JVI.78.19.10833-10836.2004","article-title":"Activation by inflammatory stimuli increases neutrophil binding of human immunodeficiency virus type 1 and subsequent infection of lymphocytes","volume":"78","author":"Gabali","year":"2004","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.febslet.2004.11.062","article-title":"Human neutrophil \u03b1-defensin 4 inhibits HIV-1 infection in vitro","volume":"579","author":"Wu","year":"2005","journal-title":"FEBS Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 Infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1003993","DOI":"10.1371\/journal.ppat.1003993","article-title":"Immune suppression by neutrophils in HIV-1 infection: Role of PD-L1\/PD-1 pathway","volume":"10","author":"Bowers","year":"2014","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1086\/313642","article-title":"Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor","volume":"30","author":"Kuritzkes","year":"2000","journal-title":"Clin Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3109\/08830185.2014.893301","article-title":"Neutropenia during HIV infection: adverse consequences and remedies","volume":"33","author":"Shi","year":"2014","journal-title":"Int Rev Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0170753","DOI":"10.1371\/journal.pone.0170753","article-title":"Incidence of severe neutropenia in HIV-infected people starting antiretroviral therapy in West Africa","volume":"12","author":"Leroi","year":"2017","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/ajhp\/56.suppl_5.S9","article-title":"Neutrophil deficiency and dysfunction in HIV-infected patients","volume":"56","author":"Pitrak","year":"1999","journal-title":"Am J Health Syst Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000353588","article-title":"Interactions between human immunodeficiency virus type 1 and polymorphonuclear neutrophils","volume":"6","author":"Casulli","year":"2014","journal-title":"J Innate Immun."},{"key":"B28","first-page":"597","article-title":"Reactive oxygen species in HIV infection","volume":"3","author":"Couret","year":"2016","journal-title":"EC Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2249.2007.03524.x","article-title":"Mechanisms of neutrophil death in human immunodeficiency virus-infected patients: role of reactive oxygen species, caspases and map kinase pathways","volume":"150","author":"Salmen","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10495-006-5699-5","article-title":"HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition","volume":"11","author":"Lichtner","year":"2006","journal-title":"Apoptosis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874357900903010052","article-title":"Neutrophil apoptosis during viral infections","volume":"3","author":"Elbim","year":"2009","journal-title":"Open Virol J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s0022-3476(05)80684-5","article-title":"Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor","volume":"117","author":"Roilides","year":"1990","journal-title":"J Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2249.2011.04526.x","article-title":"Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy","volume":"167","author":"Michailidis","year":"2012","journal-title":"Clin. Exp Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/00002030-199905280-00003","article-title":"Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients","volume":"13","author":"Mastroianni","year":"1999","journal-title":"AIDS."},{"key":"B35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/1570162X15666170704101622","article-title":"Deficient phagocytosis among HIV-1 infected adults over time even in HAART setting","volume":"15","author":"Tsachouridou","year":"2017","journal-title":"Curr HIV Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1515\/CCLM.2004.035","article-title":"Immunoglobulin G Fc(gamma) receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia","volume":"42","author":"Armbruster","year":"2004","journal-title":"Clin Chem Lab Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/00002030-200105250-00002","article-title":"nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo","volume":"15","author":"Kedzierska","year":"2001","journal-title":"AIDS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1513\/AnnalsATS.201507-463OC","article-title":"Effect of antiretroviral therapy on HIV-mediated impairment of the neutrophil antimycobacterial response","volume":"12","author":"Lowe","year":"2015","journal-title":"Ann Am Thorac Soc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1007672","DOI":"10.1371\/journal.ppat.1007672","article-title":"Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection","volume":"15","author":"Hensley-McBain","year":"2019","journal-title":"PLoS Pathog."},{"key":"B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chom.2011.11.012","article-title":"Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells","volume":"11","author":"Blomgran","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000284367","article-title":"Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease","volume":"2","author":"Fox","year":"2010","journal-title":"J Innate Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.it.2016.03.005","article-title":"Aging: a temporal dimension for neutrophils","volume":"37","author":"Adrover","year":"2016","journal-title":"Trends Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days","volume":"116","author":"Pillay","year":"2010","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fimmu.2017.01185","article-title":"Human cytomegalovirus delays neutrophil apoptosis and stimulates the release of a prosurvival secretome","volume":"8","author":"Pocock","year":"2017","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000499841","article-title":"Mass cytometry reveals the immaturity of circulating neutrophils during SIV infection","volume":"12","author":"Lemaitre","year":"2020","journal-title":"J Innate Immun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s1074-7613(03)00263-2","article-title":"Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence","volume":"19","author":"Martin","year":"2003","journal-title":"Immunity."},{"key":"B47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1189\/jlb.0210112","article-title":"The bone marrow: a site of neutrophil clearance","volume":"88","author":"Rankin","year":"2010","journal-title":"J Leukoc Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"a776","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"Meintjes","year":"2017","journal-title":"S Afr J HIV Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1056\/NEJM198707233170402","article-title":"The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex","volume":"317","author":"Richman","year":"1987","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/135965350501000510","article-title":"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with co-trimoxazole in C\u00f4te d'Ivoire","volume":"10","author":"Moh","year":"2005","journal-title":"Antivir Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/archinte.166.4.405","article-title":"Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study","volume":"166","author":"Levine","year":"2006","journal-title":"Arch Intern Med."},{"key":"B52","first-page":"79284466","article-title":"Haematological profile of patients on antiretroviral therapy in a Nigerian Teaching Hospital","volume":"6","author":"Bello","year":"2016","journal-title":"RGUHS J Pharm Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/1118-8561.215034","article-title":"Effect of highly active antiretroviral therapy on neutrophil\/lymphocyte ratio using white rabbit","volume":"20","author":"Osime","year":"2017","journal-title":"Sahel Med J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00705-017-3569-9","article-title":"The role of polymorphonuclear neutrophils during HIV-1 infection","volume":"163","author":"Yaseen","year":"2018","journal-title":"Arch Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1128\/aac.34.9.1672","article-title":"Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function","volume":"34","author":"Roilides","year":"1990","journal-title":"Antimicrob Agents Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/infdis\/167.6.1406","article-title":"Depressed neutrophil superoxide production in human immunodeficiency virus infection","volume":"167","author":"Pitrak","year":"1993","journal-title":"J Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/HIV.S79956","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS (Auckl)."},{"key":"B58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/00002030-200403050-00016","article-title":"Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression: a meta-analysis","volume":"18","author":"Owen","year":"2004","journal-title":"AIDS."},{"key":"B59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/157340608783331443","article-title":"HIV protease inhibitors impact on apoptosis","volume":"4","author":"Rizza","year":"2008","journal-title":"Med Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1172\/JCI22954","article-title":"Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor","volume":"115","author":"Weaver","year":"2005","journal-title":"J Clin Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood.v98.2.383","article-title":"The HIV protease inhibitor indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals","volume":"98","author":"Chavan","year":"2001","journal-title":"Blood."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1086\/315858","article-title":"Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis","volume":"182","author":"Mastroianni","year":"2000","journal-title":"J Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1128\/CVI.00130-07","article-title":"Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition","volume":"14","author":"Hadad","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1097\/00002030-199815000-00027","article-title":"Reversal of abnormalities of neutrophil adhesion molecule expression in HIV infection following protease inhibitor therapy","volume":"12","author":"Moore","year":"1998","journal-title":"AIDS."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1128\/aac.46.10.3228-3235.2002","article-title":"Intracellular accumulation of human immunodeficiency virus protease inhibitors","volume":"46","author":"Khoo","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jac\/dkg137","article-title":"The mechanisms that control intracellular penetration of the HIV protease inhibitors","volume":"51","author":"Hoggard","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11904-019-00480-3","article-title":"Recent advances in the development of integrase inhibitors for HIV treatment","volume":"17","author":"Trivedi","year":"2020","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.3892\/mmr.2019.10777","article-title":"HIV-1 integrase inhibitors targeting various DDE transposases: Retroviral integration versus RAG-mediated recombination","volume":"20","author":"Musat","year":"2019","journal-title":"Mol Med Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1742-6405-7-44","article-title":"Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution","volume":"7","author":"Huhn","year":"2010","journal-title":"AIDS Res Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"BENCHMRK Study Teams. Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/or.17.5.1121","article-title":"HIV infection and cancer in the era of highly active antiretroviral therapy (Review) Oncol Rep","volume":"17","author":"Barbaro","year":"2007"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14441","DOI":"10.1073\/pnas.0603406103","article-title":"A variable immunoreceptor in a subpopulation of human neutrophils","volume":"103","author":"Puellmann","year":"2006","journal-title":"PNAS."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B75","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/infdis\/jis750","article-title":"Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study","volume":"207","author":"Eron","year":"2013","journal-title":"J Infect Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5045\/kjh.2011.46.4.253","article-title":"Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia","volume":"46","author":"Choi","year":"2011","journal-title":"Korean J Hematol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jaci.2014.05.040","article-title":"Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17\/IL-22 environment","volume":"134","author":"Campillo-Gimenez","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1128\/cdli.9.5.983-986.2002","article-title":"Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection","volume":"9","author":"Torre","year":"2002","journal-title":"Clin Diagn Lab Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1097\/00002030-200012010-00009","article-title":"Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy","volume":"14","author":"Monari","year":"2000","journal-title":"AIDS."},{"key":"B80","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4239\/wjd.v7.i13.271","article-title":"Preliminary study on overproduction of reactive oxygen species by neutrophils in diabetes mellitus","volume":"7","author":"Ridzuan","year":"2016","journal-title":"World J Diabetes."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms19082409","article-title":"Combination ART-induced oxidative\/nitrosative stress, neurogenic inflammation and cardiac dysfunction in HIV-1 transgenic (Tg) rats: protection by Mg","volume":"19","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12012-009-9040-8","article-title":"AZT-induced oxidative cardiovascular toxicity: attenuation by Mg-supplementation","volume":"9","year":"2009","journal-title":"Cardiovasc Toxicol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"R1102","DOI":"10.1152\/ajpregu.00268.2013","article-title":"Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats","volume":"305","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jaci.2020.02.038","article-title":"The role of neutrophils in host defense and disease","volume":"145","author":"Lehman","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1097\/00002030-200410210-00005","article-title":"Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1056\/NEJMc1202292","article-title":"Neutrophil count in African mothers and newborns and HIV transmission risk","volume":"367","author":"Kourtis","year":"2012","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1172\/JCI99420","article-title":"Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates","volume":"128","author":"Sivanandham","year":"2018","journal-title":"J Clin Invest."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41385-018-0045-0","article-title":"Neutrophil extracellular traps prevent HIV infection in the female genital tract","volume":"11","author":"Barr","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.chom.2012.05.015","article-title":"Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1","volume":"12","author":"Saitoh","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B90","doi-asserted-by":"publisher","first-page":"5186904","DOI":"10.1155\/2017\/5186904","article-title":"The role of defensins in HIV pathogenesis","volume":"2017","author":"Pace","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B91","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI21948","volume":"115","author":"Chang","year":"2005","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nri1860","article-title":"Defensins in innate antiviral immunity","volume":"6","author":"Klotman","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1172\/JCI115810","article-title":"Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system","volume":"89","author":"Klebanoff","year":"1992","journal-title":"J Clin Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1003890","DOI":"10.1371\/journal.ppat.1003890","article-title":"Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration","volume":"10","author":"Sereti","year":"2014","journal-title":"PLoS Pathog."},{"key":"B95","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/vim.2014.0137","article-title":"Human alpha-defensin HNP1 increases hiv traversal of the epithelial barrier: a potential role in STI-mediated enhancement of HIV transmission","volume":"28","author":"Valere","year":"2015","journal-title":"Viral Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","article-title":"Gut epithelial barrier and systemic inflammation during chronic HIV infection","volume":"29","author":"Somsouk","year":"2015","journal-title":"AIDS."},{"key":"B97","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/infdis\/jiv037","article-title":"Montreal Primary infection and Slow Progressor Study Groups. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection","volume":"212","author":"Jenabian","year":"2015","journal-title":"J Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/archinte.1995.00430180067008","article-title":"Neutropenia and bacterial infection in acquired immunodeficiency syndrome","volume":"155","author":"Moore","year":"1995","journal-title":"Arch Intern Med."},{"key":"B100","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V84.8.2759.2759","article-title":"Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming","volume":"84","author":"Elbim","year":"1994","journal-title":"Blood."},{"key":"B101","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.4049\/jimmunol.177.9.6405","article-title":"HIV and other lentiviral infections cause defects in neutrophil chemotaxis, recruitment, and cell structure: immunorestorative effects of granulocyte-macrophage colony-stimulating factor","volume":"177","author":"Heit","year":"2006","journal-title":"J Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1365-2249.2000.01278.x","article-title":"Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients","volume":"121","author":"Vecchiarelli","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00002030-199804000-00005","article-title":"Impaired cytokine production by neutrophils isolated from patients with AIDS","volume":"12","author":"Gasperini","year":"1998","journal-title":"AIDS."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2001-12-0191","article-title":"Host defense role of platelets: Engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation","volume":"99","author":"Youssefian","year":"2002","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities","volume":"6","author":"Nathan","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12959-018-0170-8","article-title":"Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens","volume":"16","author":"Seyoum","year":"2018","journal-title":"Thrombosis J."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3389\/fimmu.2020.01962","article-title":"Crosstalk between platelets and microbial pathogens","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood-2018-05-849307","article-title":"Platelets kill circulating parasites of all major Plasmodium species in human malaria","volume":"132","author":"Kho","year":"2018","journal-title":"Blood."},{"key":"B109","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1055\/s-0040-1708827","article-title":"A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection","volume":"46","author":"Page","year":"2020","journal-title":"Semin Thromb Hemost."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.ddmec.2011.10.001","article-title":"HIV and SIV associated thrombocytopenia: an expanding role for platelets in the pathogenesis of HIV","volume":"8","author":"Metcalf Pate","year":"2011","journal-title":"Drug Discov Today Dis Mech."},{"key":"B111","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1538-7836.2006.01749.x","article-title":"Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes","volume":"4","author":"Boukour","year":"2006","journal-title":"J Thromb Haemost."},{"key":"B112","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1128\/jvi.00136-06","article-title":"DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets","volume":"80","author":"Chaipan","year":"2006","journal-title":"J Virol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu Rev Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","article-title":"Platelets and viruses: an ambivalent relationship","volume":"67","author":"Flaujac","year":"2010","journal-title":"Cell Mol Life Sci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"eaat6263","DOI":"10.1126\/scitranslmed.aat6263","article-title":"Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4+ T cell recovery can harbor replication-competent HIV despite viral suppression","volume":"12","author":"Real","year":"2020","journal-title":"Sci Transl Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/bloodadvances.2020002420","article-title":"Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation","volume":"4","author":"Simpson","year":"2020","journal-title":"Blood Adv."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.4049\/jimmunol.1302318","article-title":"Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation","volume":"192","author":"Singh","year":"2014","journal-title":"J Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1097\/00003246-200205001-00020","article-title":"The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis","volume":"30","author":"Zimmerman","year":"2002","journal-title":"Crit Care Med."},{"key":"B119","unstructured":"Biochemistry, platelet activating factor. In: StatPearls AshrafMA NookalaV 32491324"},{"key":"B120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.155.1.316","article-title":"Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide","volume":"155","author":"Camussi","year":"1995","journal-title":"J Immunol."},{"key":"B121","first-page":"191","article-title":"The role of platelet-activating factor in chronic inflammation, immune activation, and comorbidities associated with HIV infection","volume":"17","author":"Kelesidis","year":"2015","journal-title":"AIDS Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0003319711420608","article-title":"Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients","volume":"63","author":"Tsoupras","year":"2012","journal-title":"Angiology."},{"key":"B123","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1054\/blre.2001.0188","article-title":"HIV-related thrombocytopenia","volume":"16","author":"Scaradavou","year":"2002","journal-title":"Blood Rev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/ATVBAHA.120.314180","article-title":"Platelets endocytose viral particles and are activated via TLR (Toll-Like Receptor) signaling","volume":"40","author":"Banerjee","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/jac\/dkn333","article-title":"Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors","volume":"62","author":"von Hentig","year":"2008","journal-title":"J Antimicrob Chemother."},{"key":"B127","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QAI.0b013e3182439355","article-title":"Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression","volume":"59","author":"Mayne","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1097\/QAD.0000000000000415","article-title":"Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen","volume":"28","author":"Tunjungputri","year":"2014","journal-title":"AIDS."},{"key":"B129","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00281-011-0286-4","article-title":"Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum","volume":"34","author":"Vieira-de-Abreu","year":"2012","journal-title":"Semin Immunopathol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"14999","DOI":"10.1038\/s41598-018-33403-0","article-title":"Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals","volume":"8","author":"Mesquita","year":"2018","journal-title":"Sci Rep."},{"key":"B131","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","article-title":"Risk of coronary heart disease in patients with HIV infection","volume":"11","author":"Zanni","year":"2014","journal-title":"Nat Rev Cardiol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1538-7836.2011.04242.x","article-title":"Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy","volume":"9","author":"Landr\u00f8","year":"2011","journal-title":"J Thromb. Haemost."},{"key":"B133","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O'Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B134","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/hiv.12270","article-title":"The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection","volume":"16","author":"O'Halloran","year":"2015","journal-title":"HIV Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.thromres.2015.01.031","article-title":"The evaluation of platelet function in HIV infected, asymptomatic treatment-na\u00efve individuals using flow cytometry","volume":"135","author":"Nkambule","year":"2015","journal-title":"Thromb Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jinf.2015.01.005","article-title":"HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity","volume":"70","author":"Pastori","year":"2015","journal-title":"J Infect."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/QAD.0000000000001547","article-title":"Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation","volume":"31","year":"2017","journal-title":"AIDS."},{"key":"B138","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-016-0588-4","article-title":"Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV?","volume":"14","author":"Sabin","year":"2016","journal-title":"A cohort collaboration. BMC Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0000000000001642","article-title":"Recent abacavir use increases risk of type 1 and type 2 myocardial infarctions among adults with HIV","volume":"78","author":"Elion","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2325957417752256","DOI":"10.1177\/2325957417752256","article-title":"Prevalence of non-AIDS comorbidities and factors associated with metabolic complications among HIV-Infected patients at a Thai referral hospital","volume":"17","author":"Nakaranurack","year":"2018","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1097\/QAD.0b013e32834d3cc3","article-title":"Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase","volume":"25","author":"Baum","year":"2011","journal-title":"AIDS."},{"key":"B143","first-page":"S9","article-title":"Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations","volume":"15","author":"Gresele","year":"2014","journal-title":"Rev Cardiovasc Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/infdis\/jir509","article-title":"Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy","volume":"204","author":"Satchell","year":"2011","journal-title":"J Infect Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1160\/TH12-07-0504","article-title":"In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients","volume":"110","author":"Falcinelli","year":"2013","journal-title":"Thromb Haemost."},{"key":"B146","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1093\/jac\/dkw303","article-title":"Abacavir has no prothrombotic effect on platelets in vitro","volume":"71","author":"Diallo","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B147","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.antiviral.2017.03.001","article-title":"Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis","volume":"141","author":"Alvarez","year":"2017","journal-title":"Antiviral Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/bph.14589","article-title":"Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk","volume":"176","author":"Taylor","year":"2019","journal-title":"Br J Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e59950","DOI":"10.1371\/journal.pone.0059950","article-title":"Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals","volume":"8","author":"Davidson","year":"2013","journal-title":"PLoS ONE."},{"key":"B150","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.4049\/jimmunol.178.5.3226","article-title":"Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia","volume":"178","author":"Sui","year":"2007","journal-title":"J Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/0003319719845186","article-title":"Platelet to lymphocyte ratio in cardiovascular diseases: A systemic review","volume":"70","author":"Kurtul","year":"2019","journal-title":"Angiology."},{"key":"B152","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12879-018-3198-2","article-title":"Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy; a multicentre retrospective cohort study from 2007 to 2015","volume":"18","author":"Quiros-Roldan","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e0187185","DOI":"10.1371\/journal.pone.0187185","article-title":"HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-\u03b21 and can be suppressed by exogenous carbon monoxide","volume":"12","author":"Laurence","year":"2017","journal-title":"PLoS ONE."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1182\/blood-2019-126225","article-title":"Differential effects of HIV protease inhibitors on release activation of platelet-derived TGF-\u03b21: potential association with HIV-Linked CVD","volume":"134","author":"Karim","year":"2019","journal-title":"Blood."},{"key":"B155","unstructured":"Coagulation Abnormalities in HIV: What's the Clot Got to Do With It? TaylorKA FerrettiF CerroneM KhawajaAA YipW Marta BoffitoM"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e000823","DOI":"10.1136\/openhrt-2018-000823","article-title":"HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies","volume":"5","author":"Laurence","year":"2018","journal-title":"Open Heart."},{"key":"B158","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fcimb.2013.00045","article-title":"PGE(2) suppression of innate immunity during mucosal bacterial infection","volume":"3","author":"Agard","year":"2013","journal-title":"Front Cell Infect Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.thromres.2018.07.003","article-title":"The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro","volume":"169","author":"Loelius","year":"2018","journal-title":"Thromb Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1097\/QAD.0000000000001993","article-title":"A switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals","volume":"32","author":"van der Heijden","year":"2018","journal-title":"AIDS."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/QAD.0b013e328359f29c","article-title":"Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir","volume":"26","author":"Martinez","year":"2012","journal-title":"AIDS."},{"key":"B162","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2012.08.010","article-title":"LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy","volume":"225","author":"Saumoy","year":"2012","journal-title":"Atherosclerosis."},{"key":"B163","article-title":"Comprehensive lipid evaluation in patients switching from PI\/r-based cART to a RAL-based cART: The SPIRAL Substudy. In: Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections (CROI); 27 February to 2 March 2011","author":"Saumoy","year":""},{"key":"B164","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/COH.0000000000000417","article-title":"Are we successfully managing cardiovascular disease in people living with HIV?","volume":"12","author":"Hatleberg","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"B166","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/157016211795945278","article-title":"Neutral actions of Raltegravir on adipogenesis, glucose metabolism and lipolysis in 3T3-L1 adipocytes","volume":"9","author":"P\u00e9rez-Matute","year":"2011","journal-title":"Curr HIV Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/QAI.0b013e3180322542","article-title":"Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction","volume":"44","author":"Wang","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B168","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/QAI.0b013e318289439a","article-title":"Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification","volume":"63","author":"Massanella","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B170","unstructured":"Where Is HIV Going and What Is It Doing BomselM RealF CapronC SennepinA ZhuA IzopetJ"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2169\/internalmedicine.8377-16","article-title":"Severe thrombocytopenia during dolutegravir-containing antiretroviral therapy","volume":"56","author":"Nakaharai","year":"2017","journal-title":"Intern Med."},{"key":"B172","unstructured":""},{"key":"B173","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/039463201202500127","article-title":"Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir\/lamivudine\/efavirenz HAART regimen","volume":"25","author":"Chini","year":"2012","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1089\/AID.2011.0202","article-title":"Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF\/emtricitabine\/efavirenz HAART regimen","volume":"28","author":"Chini","year":"2012","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B175","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1476-511X-13-90","article-title":"In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients","volume":"13","author":"Papakonstantinou","year":"2014","journal-title":"Lipids Health Dis."},{"key":"B176","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1074\/jbc.M609641200","article-title":"A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase","volume":"282","author":"Shindou","year":"2007","journal-title":"J Biol Chem."},{"key":"B177","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00042560-200111010-00003","article-title":"HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy","volume":"28","author":"Servais","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B178","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1046\/j.1537-2995.1998.38698326338.x","article-title":"Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets","volume":"38","author":"Lee","year":"1998","journal-title":"Transfusion."},{"key":"B179","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s11239-015-1212-8","article-title":"Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals","volume":"40","author":"Nkambule","year":"2015","journal-title":"J. Thrombosis Thrombolysis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/cmi.2014.66","article-title":"Higher levels of circulating monocyte\u2013platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection","volume":"12","author":"Liang","year":"2015","journal-title":"Cell Mol Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/QAD.0b013e328325a87c","article-title":"HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction","volume":"23","author":"Francisci","year":"2009","journal-title":"AIDS."},{"key":"B182","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.thromres.2011.11.022","article-title":"Endothelial and platelet function alterations in HIV-infected patients","volume":"129","author":"Gresele","year":"2012","journal-title":"Thromb Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/apc.2011.0184","article-title":"Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction","volume":"25","author":"Francisci","year":"2011","journal-title":"AIDS Patient Care STDS."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01027.x","article-title":"Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy","volume":"14","author":"Arildsen","year":"2013","journal-title":"HIV Med."},{"key":"B186","doi-asserted-by":"publisher","first-page":"e65182","DOI":"10.1371\/journal.pone.0065182","article-title":"Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy","volume":"8","author":"R\u00f6nsholt","year":"2013","journal-title":"PLoS ONE."},{"key":"B187","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000091107","article-title":"Interaction of platelets, leukocytes and the endothelium","volume":"33","author":"Sachs","year":"2006","journal-title":"Transfus Med Hemother."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/glycob\/cwu056","article-title":"Glycobiology of platelet-endothelial cell interactions","volume":"24","author":"Ettulain","year":"2014","journal-title":"Glycobiology."},{"key":"B189","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2017-04-780825","article-title":"Platelet interaction with activated endothelium: mechanistic insights from microfluidics","volume":"130","author":"Coenen","year":"2017","journal-title":"Blood."},{"key":"B190","doi-asserted-by":"publisher","first-page":"568","DOI":"10.21037\/cdt.2018.07.01","article-title":"Interaction between platelets and endothelium: from pathophysiology to new therapeutic options","volume":"8","author":"Hamilos","year":"2018","journal-title":"Cardiovasc Diagn Ther."},{"key":"B191","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOH.0000000000000297","article-title":"Platelets in neutrophil recruitment to sites of inflammation","volume":"24","author":"Pitchford","year":"2017","journal-title":"Curr Opin Hematol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1152\/physiol.00011.2011","article-title":"On, around, and through: neutrophil-endothelial interactions in innate immunity","volume":"26","author":"Schmidt","year":"2011","journal-title":"Physiology (Bethesda)."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3389\/fimmu.2018.02712","article-title":"Role of platelets in leukocyte recruitment and resolution of inflammation","volume":"9","author":"Rossaint","year":"2018","journal-title":"Front Immunol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-neutrophil crosstalk in atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thromb Haemost."},{"key":"B196","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000350330","article-title":"Tissue factor expression on platelet surface during preparation and storage of platelet concentrates","volume":"40","author":"Vignoli","year":"2013","journal-title":"Transfus Med Hemother."},{"key":"B197","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.3390\/ijms21176150","article-title":"Revisting platelets and toll-like receptors (TLRs): at the interface of vascular immunity and thrombosis","volume":"21","author":"Hally","year":"2020","journal-title":"In J Mol Sci."},{"key":"B199","doi-asserted-by":"publisher","first-page":"H468","DOI":"10.1152\/ajpheart.00491.2010","article-title":"Platelets enhance neutrophil transendothelial migration via p-selectin glycoprotein ligand-1","volume":"300","author":"Lam","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget."},{"key":"B201","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40265-016-0546-7","article-title":"Serious non-AIDS events: therapeutic targets of immune activation and chronic inflammation in HIV infection","volume":"76","author":"Hsu","year":"2016","journal-title":"Drugs."},{"key":"B202","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils","volume":"9","author":"Mayadas","year":"2014","journal-title":"Annu Rev Pathol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur Heart J."},{"key":"B204","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1189\/jlb.0703358","article-title":"Delay of neutrophil apoptosis in acute coronary syndromes","volume":"75","author":"Garlichs","year":"2004","journal-title":"J Leukoc Biol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/ars.2006.8.691","article-title":"NADPH oxidases in cardiovascular health and disease","volume":"8","author":"Cave","year":"2006","journal-title":"Antioxid Redox Signal."},{"key":"B206","first-page":"195","article-title":"The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis","volume":"7","author":"Mirshafiey","year":"2008","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev."},{"key":"B208","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"6825493","DOI":"10.1155\/2017\/6825493","article-title":"HIV as a cause of immune activation and immunosenescence","volume":"2017","author":"Sokoya","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B210","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/CDLI.11.6.996-1001.2004","article-title":"Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection","volume":"11","author":"Sipsas","year":"2004","journal-title":"Clin Diagn Lab. Immunol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-0037-1613994","article-title":"Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy","volume":"84","author":"Aukrust","year":"2000","journal-title":"Thromb Haemost."},{"key":"B212","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/eurhart\/ehw550","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur Heart J."},{"key":"B213","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1084\/jem.187.3.329","article-title":"Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha","volume":"187","author":"Bombeli","year":"1998","journal-title":"J Exp Med."},{"key":"B215","unstructured":"Prothrombotic effects of abacavir in an in vivo model"},{"key":"B216","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dkt468","article-title":"Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95","volume":"69","author":"Orden","year":"2014","journal-title":"J Antimicrob Chemother."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/QAD.0b013e32833a2b02","article-title":"Abacavir and didanosine induce the interaction between human leukocytes and endothelial cells through Mac-1 upregulation","volume":"24","author":"De Pablo","year":"2010","journal-title":"AIDS."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3851\/IMP2357","article-title":"Differential effects of tenofovir\/emtricitabine and abacavir\/lamivudine on human leukocyte recruitment","volume":"17","author":"De Pablo","year":"2012","journal-title":"Antivir Ther."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1161\/01.atv.0000034707.40046.02","article-title":"HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells","volume":"22","author":"Zhong","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B220","first-page":"22","article-title":"CROI 2018: complications of HIV infection and antiretroviral Therapy","volume":"26","author":"Currier","year":"2018","journal-title":"Top Antivir Med."},{"key":"B221","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.mehy.2006.12.069","article-title":"Iatrogenic Gilbert syndrome: a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin","volume":"69","author":"McCarty","year":"2007","journal-title":"Med Hypotheses."},{"key":"B222","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4161\/cc.6.24.5022","article-title":"Bilirubin and biliverdin treatment of atherosclerotic diseases","volume":"6","author":"Ollinger","year":"2007","journal-title":"Cell Cycle."},{"key":"B223","doi-asserted-by":"publisher","first-page":"e007792","DOI":"10.1161\/JAHA.117.007792","article-title":"Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (Veterans Aging Cohort Study)","volume":"7","author":"Marconi","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B224","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/ATVBAHA.110.211789","article-title":"The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus","volume":"31","author":"Dekker","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jamacardio.2016.0846","article-title":"Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection","volume":"1","author":"Zanni","year":"2016","journal-title":"JAMA Cardiol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634386\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:09:18Z","timestamp":1698019758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.634386\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":225,"alternative-id":["10.3389\/fimmu.2021.634386"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.634386","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"article-number":"634386"}}